Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 2,307.6	$ 3,666.4
Short-term investments	687.4	785.4
Accounts receivable, net of allowances of $45.5 (2016) and $44.3 (2015)	3,622.6	3,513.0
Other receivables	564.8	558.6
Inventories	3,740.2	3,445.8
Prepaid expenses and other	792.0	604.4
Total current assets	11,714.6	12,573.6
Other Assets
Investments	3,764.3	3,646.6
Goodwill	4,045.1	4,039.9
Other intangibles, net	4,889.8	5,034.8
Sundry	2,244.9	2,220.5
Total other assets	14,944.1	14,941.8
Property and Equipment
Land, buildings, equipment, and construction in progress	16,783.1	16,660.9
Accumulated depreciation	(8,750.0)	(8,607.4)
Property and equipment, net	8,033.1	8,053.5
Total assets	34,691.8	35,568.9
Current Liabilities
Short-term borrowings and current maturities of long-term debt	648.3	6.1
Accounts payable	1,151.6	1,338.2
Employee compensation	548.7	967.0
Sales rebates and discounts	2,601.1	2,560.1
Dividends payable	0.0	539.0
Income taxes payable	114.6	358.9
Other current liabilities	2,276.6	2,460.3
Total current liabilities	7,340.9	8,229.6
Other Liabilities
Long-term debt	7,477.6	7,972.4
Accrued retirement benefits	2,106.6	2,160.3
Long-term income taxes payable	908.0	868.9
Other noncurrent liabilities	1,829.3	1,747.4
Total other liabilities	12,321.5	12,749.0
Eli Lilly and Company Shareholders' Equity
Common stock	690.3	691.3
Additional paid-in capital	5,523.0	5,552.1
Retained earnings	16,155.0	16,011.8
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss	(4,264.7)	(4,580.7)
Cost of common stock in treasury	(80.5)	(90.0)
Total Eli Lilly and Company shareholders' equity	15,009.9	14,571.3
Noncontrolling interests	19.5	19.0
Total equity	15,029.4	14,590.3
Total liabilities and equity	$ 34,691.8	$ 35,568.9